← Back to Search

Powered Hip Exoskeleton for Severe Lung Disease

N/A

Recruiting

Led By Roger Goldstein

Research Sponsored by West Park Healthcare Centre

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Modified medical research council dyspnoea score (mMRC) ≥ 2

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up an average of 7 tests over 4 weeks

Awards & highlights

Study Summary

This trial aims to test if using a powered hip exoskeleton device can help people with chronic respiratory disease walk longer and faster.

Who is the study for?

This trial is for people with stable chronic respiratory disease who experience moderate to severe difficulty breathing during activity. They must fit within the size specifications of the exoskeleton and not have skin issues, heart problems, recent lung surgery or myocardial infarction, untreated cancer, or a high risk of fractures.Check my eligibility

What is being tested?

The study tests if a powered hip exoskeleton can help patients with severe lung disease walk faster and longer by reducing the energy needed for walking. Participants will compare their walking endurance with and without this assistive device in single-case experiments.See study design

What are the potential side effects?

Potential side effects may include discomfort or skin irritation where the exoskeleton attaches, muscle strain from using the device, and possible exacerbation of existing health conditions due to increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I often feel short of breath when moving around.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ an average of 7 tests over 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~an average of 7 tests over 4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and an average of 7 tests over 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

walking endurance time

Trial Design

1Treatment groups

Experimental Treatment

Group I: exoskeleton assistExperimental Treatment1 Intervention

A powered exoskeleton describes a wearable robot designed around the shape and function of the human body with segments and joints externally coupled to those of the user. The exoskeleton includes a belt frame, sensors that detect a user's desired movements, a computerized controller, motors and actuators, and lightweight batteries.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

exoskeleton assist

2018

N/A

~10

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

West Park Healthcare CentreLead Sponsor

31 Previous Clinical Trials

2,246 Total Patients Enrolled

Roger GoldsteinPrincipal InvestigatorWest Park Healthcare Centre

Media Library

exoskeleton assist Clinical Trial Eligibility Overview. Trial Name: NCT05835271 — N/A

Lung Disease Research Study Groups: exoskeleton assist

Lung Disease Clinical Trial 2023: exoskeleton assist Highlights & Side Effects. Trial Name: NCT05835271 — N/A

exoskeleton assist 2023 Treatment Timeline for Medical Study. Trial Name: NCT05835271 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being sought for this medical experiment?

"Sources found on clinicaltrials.gov point to this study's ongoing recruitment efforts, launched initially April 21st 2023 and recently updated April 17th of the same year."

Answered by AI

How many people can the trial accommodate at maximum capacity?

"Affirmative. According to the clinical trials website, enrollment for this medical trial is currently open with 12 participants needed from one site. The initial posting was on April 21st 2023 and it has been recently updated on the 17th of the same month."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Powered Assist Hip Exoskeleton to Improve Ambulation in Severe Lung Disease

Roger Goldstein 2023. "Powered Assist Hip Exoskeleton to Improve Ambulation in Severe Lung Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05835271.

All > Lung Disease